Answer capsule
AI-assisted market and company research can accelerate a deal screen, but it should not become an acquisition, partnership, or portfolio thesis without traceable sources and accountable judgment.
What the source establishes
- S&P Global's current Capital IQ Pro page describes market, company, transaction, research, and document intelligence in one platform.
- The page presents AI-assisted capabilities including ChatIQ, Document Intelligence, Chart Explainer, and top-line insights.
- The provider positions the product for research and decisions that can include deal sourcing, due diligence, and strategic planning.
- Those capabilities do not independently establish the source completeness, assumptions, counterevidence, valuation consequence, strategic fit, or approval behind a specific deal thesis.
Speed is not a deal thesis
S&P Global describes Capital IQ Pro as a platform combining market and company data, research, documents, transactions, and AI-assisted analysis. That can reduce the effort needed to find a filing, compare companies, extract a point, or assemble an initial screen. A CEO should still treat the resulting top-line insight as a research lead. An acquisition, partnership, divestiture, or portfolio decision depends on strategic fit, price, control, integration capacity, customer and workforce consequences, financing, risk, and credible alternatives. None of those judgments is established merely because an answer is concise, cites familiar data, or appears inside an authoritative platform.
Build the evidence chain
Every material assertion in a deal thesis should link to the underlying document, dataset, date, entity, period, and definition. The record should identify whether the point was quoted, calculated, summarized, inferred, or supplied by an analyst. It should preserve the query and output needed to reproduce the research while excluding unauthorized confidential data. Management assumptions should be separated from provider data, and each assumption should name an owner, range, sensitivity, and refresh trigger. If an AI-assisted answer combines sources or cannot expose a reliable origin, the team should use it to locate primary evidence rather than carry the answer itself into the investment case.
Require counterevidence before conviction
A deal team should test the thesis against disconfirming evidence: customer concentration, churn or demand quality, competitive responses, technology and data liabilities, regulatory exposure, management dependence, workforce and integration constraints, financing conditions, and a credible no-deal alternative. Analysts should reconcile inconsistent company, market, and transaction definitions instead of selecting the figure that makes the case look strongest. The decision pack should show which evidence changed the view, which uncertainties remain, and how those uncertainties affect valuation, structure, diligence, integration, or walk-away terms. That makes the AI contribution observable without allowing an attractive summary to manufacture confidence.
Keep approval with accountable leaders
The CEO or delegated corporate-development leader should own the thesis, while finance, strategy, operating, technology, security, workforce, legal, and other specialists sign the claims within their authority. The board receives a traceable case, not an AI verdict. Stage gates should specify the evidence required to move from screen to diligence, indication, negotiation, and approval, along with conditions that stop or reopen the decision. New filings, market moves, diligence findings, or assumption changes should trigger a refresh. When a material claim lacks an accessible source, a named owner, or a tested downside, it should remain an uncertainty and cannot be converted into certainty by the platform's brand or interface.
Turn this source into a reviewable decision
For AI for CEOs, use this briefing as a dated decision record rather than a substitute for the source. Preserve S&P Capital IQ Pro, the exact URL, the August 19, 2026 review date, the supported facts above, the editorial interpretation, the limitations, and any buyer-specific evidence. Link that record to the decisions most directly affected: M&A and partnership diligence; Strategy and scenario intelligence; Portfolio and capital allocation; Board governance and oversight. State whether the source changes the scope, evidence requirement, control, sequence, or only the language used to describe the decision.
Before action, name the accountable owner, affected population and workflow, exact offering or configuration, source data and rights, human decision point, exception and appeal path, complete cost, expected benefit, failure and stop conditions, retained evidence, and next review date. Keep official facts, provider statements, buyer observations, representative tests, measured outcomes, editorial inferences, and unknowns visibly separate. Reopen the record when the source, offer, model, integration, data, policy, population, responsible person, or measured result changes.
Limitations and unknowns
S&P Global is the provider source, and its Capital IQ Pro page was access-guarded during the 2026-08-19 automated check. Current official page evidence describes market, company, transaction, research, document, and AI-assisted analysis capabilities. It does not independently establish a buyer's entitlement, data coverage and currency, source completeness, model behavior, analyst assumptions, counterevidence, strategic fit, valuation, diligence quality, integration feasibility, board approval, or deal outcome. Current contracts, accessible primary records, data definitions, analyst workpapers, diligence evidence, and qualified strategy, finance, operations, technology, security, workforce, procurement, legal, and board review control.
Decision test
Ask whether the source changes the decision itself, the evidence required, the implementation sequence, or only the language used to describe an existing capability. Record which claims are directly supported, which are provider statements, which require an independent test, and which remain unknown. A source-linked review should make uncertainty easier to see, not bury it inside a blended score.
Questions to take into review
- Which AI assets are actually owned?
- What model, cloud, data, and licensing dependencies persist after close?
- Which external and internal evidence anchors the scenario?
- What would falsify the thesis?
- What is the value mechanism and accountable owner?
- What competing investment is displaced?
- Which AI matters to strategy or risk?
- What evidence supports management's claims?
The publication supports research and executive decision preparation. It does not provide legal, financial, accounting, employment, clinical, cybersecurity, investment, procurement, or implementation advice.